|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/28 | (2013.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K 16/2809 | (2013.01) | ||
| C07K 16/32 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K2317/52 | (2013.01) | ||
| C07K2317/60 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/71 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K 16/00 | (2013.01) | ||
| C07K2317/64 | (2013.01) | ||
| C07K 16/468 | (2013.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 11/08 | (2018.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 19/04 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 33/00 | (2018.01) | ||
| A61P 33/02 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 2970477 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14717954.3 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/029253 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/144722 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361791424 P | 2013-03-15 | US |
| (72) |
BORGES, Luis G. , US
BAEUERLE, Patrick A. , DE
YAN, Wei , US
MICHAELS, Mark L. , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | BISPECIFIC-FC MOLECULES |
| BISPECIFIC-FC MOLECULES |